Project GMMG-DANTE

Basic data

Title:
GMMG-DANTE
Duration:
01/12/2016 to 30/11/2020
Abstract / short description:
A phase 2, open-label, multicentric trial. Daratumumab in combination with Bortezomib and Dexamethasone in subjects with relapsed and refractory Multiple Myeloma and severe renal impairment including subjects undergoing hemodialysis.
Keywords:
Multiple Myeloma

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Local organizational units

Internal Medicine Department II
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine

Funders

Neuss, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.